Bristol Myers Squibb’s $13.1 Billion Acquisition Of MyoKardia

Goodwin Procter LLP advised MyoKardia, Inc., while Kirkland & Ellis LLP advised Bristol Myers Squibb on the deal. MyoKardia, Inc. (Nasdaq: MYOK) announced its definitive merger agreement…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here